Cargando…
2-deoxy-d-glucose therapy for preventing inflammatory cascade in COVID19 patients
Autor principal: | Nair, Abhijit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477764/ https://www.ncbi.nlm.nih.gov/pubmed/34658746 http://dx.doi.org/10.4103/sja.sja_419_21 |
Ejemplares similares
-
Non-steroidal anti-inflammatory drugs in COVID-19 patients- What is the verdict?
por: Nair, Abhijit
Publicado: (2021) -
Increased FluoroDeoxyGlucose (FDG) Avidity Following COVID-19 Vaccination
por: Nassar, Mo’ath, et al.
Publicado: (2022) -
Importance of diffuse versus focal F-18 fluoro-deoxy-glucose uptake in oesophagus
por: Santhosh, Sampath, et al.
Publicado: (2011) -
Radiotherapeutic use of 2-deoxy-2-[(18)F]fluoro-D-glucose – a comment
por: Meyer, Michael Andrew
Publicado: (2004) -
Practical Consideration Regarding Stability of F-18 2-Deoxy-2-[(18)F] Fluoro-D-Glucose, Procured from a Distant Commercial Production Site
por: Vatsa, Rakhee, et al.
Publicado: (2020)